REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Koneks Tov (Ukraine)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka Koneks Tov Profile Updated: March 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Apteka Koneks Tov is a company in Ukraine, with a head office in M. Vinnytsia. The company operates in the Pharmacies and Drug Stores industry. Apteka Koneks Tov was incorporated on September 06, 2026. 201 (2024) employees currently work for Apteka Koneks Tov. From the latest financial highlights, Apteka Koneks Tov reported a net sales revenue increase of 22.64% in Q2C2026. There was a total growth of 30.18% in Apteka Koneks Tov’s total assets over the same period. The net profit margin of Apteka Koneks Tov decreased by 0.75% in 2026.

Headquarters
Bud. 136-G, Vul. Kyivska
M. Vinnytsia; Vinnytsia Oblast; Postal Code: 21022

Contact Details: Purchase the Apteka Koneks Tov report to view the information.

Basic Information
Total Employees:
Purchase the Apteka Koneks Tov report to view the information.
Financial Auditors:
Purchase the Apteka Koneks Tov report to view the information.
Incorporation Date:
September 06, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Apteka Koneks Tov report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
22.64%
Total Operating Revenue
22.64%
Operating Profit
-60.32%
Net Profit/Loss for the Period
-55.27%
Total Assets
30.18%
Total Equity
3.07%
Operating Profit Margin
-1.1%
Net Profit Margin
-0.75%
Return on Equity (ROE)
-3.88%
Quick Ratio
0.14%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?